Robeco Institutional Asset Management B.V. raised its holdings in Innoviva, Inc. (NASDAQ:INVA – Get Rating) by 0.3% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 520,899 shares of the biotechnology company’s stock after buying an additional 1,619 shares during the period. Robeco Institutional […]
Los Angeles Capital Management LLC lessened its position in shares of Innoviva, Inc. (NASDAQ:INVA – Get Rating) by 0.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 184,008 shares of the biotechnology company’s stock after selling 1,594 shares during […]
Stock Market | FinancialContent Business Page financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.
EF Hutton Acquisition Co. I restated their buy rating on shares of Innoviva (NASDAQ:INVA – Get Rating) in a research note released on Thursday, Benzinga reports. The firm currently has a $22.50 price target on the biotechnology company’s stock. A number of other analysts have also recently issued reports on the company. StockNews.com assumed coverage […]
Royalties at $65.6 million in the third quarter of 2022, compared to $65.7 million in the same quarter of 2021, for RELVAR®/BREO® ELLIPTA® and ANORO® ELLIPTA®
Announced new. | November 9, 2022